TA
SAGE

Teachers Advisors’s Sage Therapeutics SAGE Stock Holding History

Teachers Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$46.7M Buy
293,384
+163,954
+127% +$23.7M 0.06% 345
2018
Q4 		$12.4M Sell
129,430
-16,688
-11% -$1.91M 0.02% 826
2018
Q3 		$20.6M Sell
146,118
-10,469
-7% -$1.62M 0.02% 710
2018
Q2 		$24.5M Sell
156,587
-85,001
-35% -$13.3M 0.03% 628
2018
Q1 		$38.9M Buy
241,588
+103,909
+75% +$17.6M 0.05% 416
2017
Q4 		$22.7M Buy
137,679
+9,266
+7% +$898K 0.03% 657
2017
Q3 		$8M Sell
128,413
-2,264
-2% -$178K 0.01% 1114
2017
Q2 		$10.4M Buy
130,677
+12,605
+11% +$911K 0.01% 982
2017
Q1 		$8.39M Buy
118,072
+68,776
+140% +$4.03M 0.01% 1058
2016
Q4 		$2.52M Buy
49,296
+6,419
+15% +$303K ﹤0.01% 1633
2016
Q3 		$1.97M Hold
42,877
– – ﹤0.01% 1696
2016
Q2 		$1.29M Buy
42,877
+20,504
+92% +$684K ﹤0.01% 1901
2016
Q1 		$717K Buy
22,373
+1,694
+8% +$59.6K ﹤0.01% 2152
2015
Q4 		$1.21M Buy
20,679
+205
+1% +$10.2K ﹤0.01% 1912
2015
Q3 		$866K Buy
20,474
+459
+2% +$28.3K ﹤0.01% 2078
2015
Q2 		$1.46M Buy
20,015
+12,106
+153% +$778K ﹤0.01% 1895
2015
Q1 		$397K Buy
7,909
+228
+3% +$9.8K ﹤0.01% 2569
2014
Q4 		$281K Buy
7,681
+2,321
+43% +$86.5K ﹤0.01% 2751
2014
Q3 		$169K Buy
+5,360
New +$155K ﹤0.01% 2952

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Teachers Advisors's SAGE Position: Q1 2019 in Review

Teachers Advisors increased its Sage Therapeutics (SAGE) stake by 127% in Q1 2019, buying an estimated $23.7M and bringing the position to 293,384 shares worth $46.7M. The position accounts for 0.06% of the portfolio, ranked #345.

Teachers Advisors first reported a position in SAGE in Q3 2014 and has held it in 19 quarters since. 267 funds tracked by Wall St. Rank hold SAGE as of Q1 2019.

  • Teachers Advisors held 293,384 shares of Sage Therapeutics worth $46.7M as of Q1 2019.
  • Teachers Advisors bought 163,954 Sage Therapeutics shares in Q1 2019, an estimated $23.7M.
  • Sage Therapeutics made up 0.06% of Teachers Advisors's portfolio in Q1 2019, its #345 holding.
  • Teachers Advisors first reported a position in Sage Therapeutics in Q3 2014 and has held it in 19 quarters since.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.